• The PP2A activator FTY720 induces apoptosis of chronic myelogenic leukemia cells through activation of Bim and Bid.• FTY720 overcomes tyrosine kinase inhibitor resistance caused by Abl kinase domain mutations. The gene discussed is BCL2L11; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.